MarsyasI – clinical phase 1 study completed

Marsyas I: A Prospective Randomized Double-Blinded Placebo controlled, explorative Phase I trial to investigate the Safety and Tolerability of two different doses of Topically Administered APOSEC^TM in Healthy male subjects with Artificial Dermal Wounds, (ClinicalTrials.gov Identifier: NCT02284360) initiated on 23 October 2014 was completed on 5 February 2016: Study Report – Synopsis
PDF Download